Semaglutide as a Cardiovascular Disease Modifier: Semaglutide belongs to the class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which have been found to offer cardioprotective effects beyond glycemic control
Risk of bias was graded as unclear, high, or low
The addition of GLP-1 medications is a natural extension, particularly for those of us whove pursued additional training in obesity medicine or functional medicine
126 Bioactive oxidized phospholipids (oxPLs) bind to LRP6 in bone marrow mesenchymal stem cells (BMSCs) and induce their endocytosis, contributing to the inhibition of Wnt signalling and diminishing osteoblast differentiation ability
GHK-Cu accelerates wound healing, improves the take of transplanted skin, and enhances keratinocyte proliferation and epidermal regeneration. Pickart, Oxidative Medicine and Cellular Longevity 3